A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Trial Identifier:	D7340C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	June 2025
Primary Completion Date:	September 2026
Study Completion Date:	September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Harrow, GB, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.